Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06284213
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-02-16
Brief Title:
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
Sponsor:
Organization:
Massachusetts General Hospital
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
The MarkVCID study will collect serum plasma and packed cell samples from all participants each year as possible Consortium sites are expected to collect and store for consortium use between 4-5ml plasma 4-5ml serum 5ml preferred for both sample types when possible and 3-4ml packed cells for DNA extraction
Enrollment Count:
1800
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 104212 |
Who Masked List: